Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Agios Pharmaceuticals (8AP.STU) Q3 2026 Earnings
8AP.STU
30
Jul
Confirmed
Q1 2026
Q2 2026
Next
-1.65
-1.58
-1.51
-1.45
Details
Expected EPS
-1.45170399056
Actual EPS
N/A
Surprise EPS
1.45
Surprise Percent
+100%
Description
Agios Pharmaceuticals (8AP.STU) will report earnings of for Q3 2026 on July 30, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login